Punit Dhillon - 07 Aug 2026 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: SKYE
Reported as of: 07 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 17:37:52 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: Punit Dhillon

Key filing fact

Punit Dhillon filed Form 4 for Skye Bioscience, Inc. (SKYE) on 07 Aug 2026.

Key facts

This page summarizes Punit Dhillon's Form 4 filing for Skye Bioscience, Inc. (SKYE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 17:37.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001425052 Primary reporting owner

DHILLON PUNIT

Relationship: Chief Executive Officer, Director
Address: 11250 EL CAMINO REAL, SUITE 100, C/O SKYE BIOSCIENCE, INC., SAN DIEGO
Signature: Punit Dhillon
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SKYE transaction

Common Stock

Award

Transaction value
Shares: +1,090,000
Change %: +330%
Price: $0.000000^*
Shares after: 1,419,823
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1, F2

SKYE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,343
Date: 07 Aug 2026
Ownership: Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award that will vest on August 31, 2027 subject to (a) the Reporting Person's continued employment through such date or (b) the termination of the Reporting Person's employment by the Company for any reason other than For Cause, By Death or By Disability (each, as defined in the Reporting Person's Executive Employment Agreement), provided the Reporting Person executes and does not revoke the release agreement appended to the Reporting Person's Executive Employment Agreement.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's common stock.